Sign in
4

Changes in Ownership

Karyopharm Therapeutics Inc. Filed Acc 0001209191-23-014838

President and CEO sold 33,033 shares at $3.03 ($100,064)

  • President and CEO acquired 252,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Paulson Richard A. · President and CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-02-28 Grant or award : show line 1 in the form +252,000 856,655 D
2023-03-01 Sale : show line 2 in the form −33,033 $3.03 $100,064 823,622 D
Open-market sales · 33,033 sh · avg $3.03 · $100,064
Loading xslF345X03/doc4.xml…